Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
PubliRES - Publications, Research, Expertise and Skills Home
Italiano
English
Home
Profili
Unità di ricerca
Prodotti della ricerca
Dataset
Ricerca per competenza, nome o affiliazione
dasatinib-blinatumomab for ph positive acute lymphoblastic leukemia in adults
Simona Sica
Dipartimento di Scienze radiologiche ed ematologiche
Facoltà di Medicina e Chirurgia "A.Gemelli"
Ambito disciplinare: Clinica Medica Specialistica
Risultato della ricerca
:
Contributo in rivista
›
Articolo in rivista
24
Citazioni (Scopus)
Panoramica
Fingerprint
Fingerprint
Entra nei temi di ricerca di 'dasatinib-blinatumomab for ph positive acute lymphoblastic leukemia in adults'. Insieme formano una fingerprint unica.
Ordina per
Peso
Alfabetico
Medicine and Dentistry
Blinatumomab
100%
Patient
100%
Combination Therapy
60%
Acute Lymphoblastic Leukemia
60%
Dasatinib
60%
Spontaneous Remission
40%
Age
40%
Disease Free Survival
40%
Therapeutic Procedure
40%
Adult
40%
Follow up
20%
Adverse Event
20%
Overall Survival
20%
Minimal Residual Disease
20%
Glucocorticoid
20%
Philadelphia 1 Chromosome
20%
Tyrosine-Kinase Inhibitor
20%
Aberration
20%
Motivation
20%
Relapse
20%
Inpatient
20%
Biochemistry, Genetics and Molecular Biology
Dasatinib
60%
Mutation
40%
Disease Free Survival
40%
Age
40%
IKZF1
40%
Group Trial
40%
Overall Survival
20%
Glucocorticoid
20%
Philadelphia Chromosome
20%
PAX5
20%
CDKN2B
20%
Genetics
20%
Motivation
20%
Relapse
20%
Immunology and Microbiology
Blinatumomab
100%
Age
40%
Mutation
40%
Bone Marrow
40%
Philadelphia 1 Chromosome
20%
Glucocorticoid
20%
Overall Survival
20%